Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anthony D Ho

Showing results (301-310 of 346) with videos related to

Pageof 35
Sort By:
BMJ Open|May 22, 2019
Treatment of patients with relapsed or refractory CD19+ lymphoid disease with T lymphocytes transduced by RV-SFG.CD19.CD28.4-1BBzeta retroviral vector: a unicentre phase I/II clinical trial protocolMaria-Luisa Schubert, Anita Schmitt, Leopold Sellner, et al.
European Journal of Heart Failure|October 1, 2009
Staged heart transplantation and chemotherapy as a treatment option in patients with severe cardiac light-chain amyloidosisArnt V Kristen, Falk-Udo Sack, Stefan O Schonland, et al.
European Journal of Cancer (Oxford, England : 1990)|July 2, 2016
Vorinostat in refractory soft tissue sarcomas - Results of a multi-centre phase II trial of the German Soft Tissue Sarcoma and Bone Tumour Working Group (AIO)Thomas Schmitt, Regine Mayer-Steinacker, Frank Mayer, et al.
British Journal of Haematology|April 27, 2011
Diffusion-weighted imaging for non-invasive and quantitative monitoring of bone marrow infiltration in patients with monoclonal plasma cell disease: a comparative study with histologyJens Hillengass, Tobias Bäuerle, Reiner Bartl, et al.
The Lancet. Oncology|April 11, 2008
Prognostic significance of maximum tumour (bulk) diameter in young patients with good-prognosis diffuse large-B-cell lymphoma treated with CHOP-like chemotherapy with or without rituximab: an exploratory analysis of the MabThera International Trial Group (MInT) studyMichael Pfreundschuh, Anthony D Ho, Eva Cavallin-Stahl, et al.
British Journal of Haematology|March 19, 2016
Single versus tandem high-dose melphalan followed by autologous blood stem cell transplantation in multiple myeloma: long-term results from the phase III GMMG-HD2 trialElias K Mai, Axel Benner, Uta Bertsch, et al.
Blood|March 25, 2006
Improved leukemia-free survival after postconsolidation immunotherapy with histamine dihydrochloride and interleukin-2 in acute myeloid leukemia: results of a randomized phase 3 trialMats Brune, Sylvie Castaigne, John Catalano, et al.
Communications Biology|May 20, 2021
DNA methylation changes during long-term in vitro cell culture are caused by epigenetic driftJulia Franzen, Theodoros Georgomanolis, Anton Selich, et al.
Haematologica|May 28, 2017
Reduced hematopoietic stem cell frequency predicts outcome in acute myeloid leukemiaWenwen Wang, Thomas Stiehl, Simon Raffel, et al.
Blood|January 26, 2017
Marker chromosomes can arise from chromothripsis and predict adverse prognosis in acute myeloid leukemiaTilmann Bochtler, Martin Granzow, Friedrich Stölzel, et al.
Pageof 35

Showing results (301-310 of 346) with videos related to

Sort By:
Pageof 35
BMJ Open|May 22, 2019
Treatment of patients with relapsed or refractory CD19+ lymphoid disease with T lymphocytes transduced by RV-SFG.CD19.CD28.4-1BBzeta retroviral vector: a unicentre phase I/II clinical trial protocolMaria-Luisa Schubert, Anita Schmitt, Leopold Sellner, et al.
European Journal of Heart Failure|October 1, 2009
Staged heart transplantation and chemotherapy as a treatment option in patients with severe cardiac light-chain amyloidosisArnt V Kristen, Falk-Udo Sack, Stefan O Schonland, et al.
European Journal of Cancer (Oxford, England : 1990)|July 2, 2016
Vorinostat in refractory soft tissue sarcomas - Results of a multi-centre phase II trial of the German Soft Tissue Sarcoma and Bone Tumour Working Group (AIO)Thomas Schmitt, Regine Mayer-Steinacker, Frank Mayer, et al.
British Journal of Haematology|April 27, 2011
Diffusion-weighted imaging for non-invasive and quantitative monitoring of bone marrow infiltration in patients with monoclonal plasma cell disease: a comparative study with histologyJens Hillengass, Tobias Bäuerle, Reiner Bartl, et al.
The Lancet. Oncology|April 11, 2008
Prognostic significance of maximum tumour (bulk) diameter in young patients with good-prognosis diffuse large-B-cell lymphoma treated with CHOP-like chemotherapy with or without rituximab: an exploratory analysis of the MabThera International Trial Group (MInT) studyMichael Pfreundschuh, Anthony D Ho, Eva Cavallin-Stahl, et al.
British Journal of Haematology|March 19, 2016
Single versus tandem high-dose melphalan followed by autologous blood stem cell transplantation in multiple myeloma: long-term results from the phase III GMMG-HD2 trialElias K Mai, Axel Benner, Uta Bertsch, et al.
Blood|March 25, 2006
Improved leukemia-free survival after postconsolidation immunotherapy with histamine dihydrochloride and interleukin-2 in acute myeloid leukemia: results of a randomized phase 3 trialMats Brune, Sylvie Castaigne, John Catalano, et al.
Communications Biology|May 20, 2021
DNA methylation changes during long-term in vitro cell culture are caused by epigenetic driftJulia Franzen, Theodoros Georgomanolis, Anton Selich, et al.
Haematologica|May 28, 2017
Reduced hematopoietic stem cell frequency predicts outcome in acute myeloid leukemiaWenwen Wang, Thomas Stiehl, Simon Raffel, et al.
Blood|January 26, 2017
Marker chromosomes can arise from chromothripsis and predict adverse prognosis in acute myeloid leukemiaTilmann Bochtler, Martin Granzow, Friedrich Stölzel, et al.
Pageof 35